Mycelium-derived compound shows promise for salmon disease resistance enhancement



A recent study has shown that β-glucans derived from the mycelium of the fungus Aspergillus niger may enhance disease resistance in Atlantic salmon.



Source link

Related articles

UN Global Seaweed Initiative: Annual meeting

Advancing sustainable seaweed value chains for climate, biodiversity...

Seaweed at Scale : A Global Perspective into Implementation

Great seaweed session at the ChangeNOW Summit on...

The Global Seaweed Coalition is hiring a fundraising manager

The Global Seaweed Coalition (GSC) is looking for...

Financing Regenerative Seaweed & Bivalves: Launch Event

🗓️ Monday 1st December; 13.00 – 14.00 GMT Join...